N-acetylcysteine and 15 deoxy-Δ12,14-prostaglandin J2 exert a protective effect against autoimmune thyroid destruction in vivo but not against interleukin-1α/interferon γ-induced inhibitory effects in thyrocytes in vitro

American Journal of Pathology

Volumn 177, Issue 1, 2010, Pages 219-228

  Poncin, Sylvie ^a   Colin, Ides M ^a   Decallonne, Brigitte ^b   Clinckspooor, Isabelle ^b   Many, Marie Christine ^a   Denef, Jean François ^a   Gérard, Anne Catherine ^a  

^a UNIVERSITÉ CATHOLIQUE DE LOUVAIN   (Belgium)

^b UNIVERSITY OF LEUVEN   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

15 DEOXY DELTA12,14 PROSTAGLANDIN J2; ACETYLCYSTEINE; CATALASE; GAMMA INTERFERON; INTERLEUKIN 1ALPHA; MESSENGER RNA; PEROXIREDOXIN 3; PEROXIREDOXIN 5; REACTIVE OXYGEN METABOLITE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ANTIOXIDANT ACTIVITY; ARTICLE; AUTOIMMUNE THYROIDITIS; CELL INFILTRATION; FEMALE; HUMAN; HUMAN TISSUE; IN VITRO STUDY; IN VIVO STUDY; MOUSE; NONHUMAN; NONOBESE DIABETIC MOUSE; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; THYROID FUNCTION; THYROID GLAND;

EID: 77954606305     PISSN: 00029440     EISSN: 15252191     Source Type: Journal    
DOI: 10.2353/ajpath.2010.091253     Document Type: Article

References (55)

1. Gerard AC, Many MC, Daumerie C, Knoops B, Colin IM: Peroxiredoxin 5 expression in the human thyroid gland. Thyroid 2005, 15:205-209 (Pubitemid 40418687)
2. Poncin S, Gerard AC, Boucquey M, Senou M, Calderon PB, Knoops B, Lengele B, Many MC, Colin IM: Oxidative stress in the thyroid gland: from harmlessness to hazard depending on the iodine content. Endocrinology 2008, 149:424-433
3. Mano T, Shinohara R, Iwase K, Kotake M, Hamada M, Uchimuro K, Hayakawa N, Hayashi R, Nakai A, Ishizuki Y, Nagasaka A: Changes in free radical scavengers and lipid peroxide in thyroid glands of various thyroid disorders. Horm Metab Res 1997, 29:351-354
4. Mutaku JF, Many MC, Colin I, Denef JF, van den Hove MF: Antigoitrogenic effect of combined supplementation with dl-alpha-tocopherol, ascorbic acid, and beta-carotene and of dl-alpha-tocopherol alone in the rat. J Endocrinol 1998, 156:551-561 (Pubitemid 28131473)
5. Nadolnik LI, Valentyukevich OI: Peculiarities of the antioxidant status of the thyroid gland. Bull Exp Biol Med 2007, 144:529-531
6. Poncin S, Colin IM, Gerard AC: Minimal oxidative load: a prerequisite for thyroid cell function. J Endocrinol 2009, 201:161-167
7. Poncin S, Van ES, Humblet K, Colin IM, Gerard AC: Oxidative stress: a required condition for thyroid cell proliferation. Am J Pathol 2010, 176:1355-1363
8. Many MC, Mestdagh C, van den Hove MF, Denef JF: In vitro study of acute toxic effects of high iodide doses in human thyroid follicles. Endocrinology 1992, 131:621-630
9. Belshaw BE, Becker DV: Necrosis of follicular cells and discharge of thyroidal iodine induced by administering iodide to iodine-deficient dogs. J Clin Endocrinol Metab 1973, 36:466-474
10. Wollman SH, Breitman TR: Changes in DNA and weight of thyroid glands during hyperplasia and involution. Endocrinology 1970, 86:322-327
11. Mahmoud I, Colin I, Many MC, Denef JF: Direct toxic effect of iodide in excess on iodine-deficient thyroid glands: epithelial necrosis and inflammation associated with lipofuscin accumulation. Exp Mol Pathol 1986, 44:259-271 (Pubitemid 16012120)
12. Many MC, Maniratunga S, Varis I, Dardenne M, Drexhage HA, Denef JF: Two-step development of Hashimoto-like thyroiditis in genetically autoimmune prone non-obese diabetic mice: effects of iodine-induced cell necrosis. J Endocrinol 1995, 147:311-320
13. Mutaku JF, Poma JF, Many MC, Denef JF, van den Hove MF: Cell necrosis and apoptosis are differentially regulated during goitre development and iodine-induced involution. J Endocrinol 2002, 172:375-386
14. Straus DS, Glass CK: Cyclopentenone prostaglandins: new insights on biological activities and cellular targets. Med Res Rev 2001, 21:185-210
15. Garg TK, Chang JY: 15-deoxy-delta 12, 14-Prostaglandin J2 prevents reactive oxygen species generation and mitochondrial membrane depolarization induced by oxidative stress. BMC Pharmacol 2004, 4:6
16. Rapoport B, McLachlan SM: Thyroid autoimmunity. J Clin Invest 2001, 108:1253-1259
17. Stassi G, De MR: Autoimmune thyroid disease: new models of cell death in autoimmunity. Nat Rev Immunol 2002, 2:195-204 (Pubitemid 37328766)
18. Colin IM, Isaac J, Dupret P, Ledant T, D'Hautcourt JL: Functional lymphocyte subset assessment of the Th1/Th2 profile in patients with autoimmune thyroiditis by flowcytometric analysis of peripheral lymphocytes. J Biol Regul Homeost Agents 2004, 18:72-76 (Pubitemid 39193432)
19. Ajjan RA, Watson PF, Findlay C, Metcalfe RA, Crisp M, Ludgate M, Weetman AP: The sodium iodide symporter gene and its regulation by cytokines found in autoimmunity. J Endocrinol 1998, 158:351-358 (Pubitemid 28407542)
20. Rasmussen AK, Bendtzen K, Feldt-Rasmussen U: Thyrocyte-interleukin-1 interactions. Exp Clin Endocrinol Diabetes 2000, 108:67-71
21. Caraccio N, Giannini R, Cuccato S, Faviana P, Berti P, Galleri D, Dardano A, Basolo F, Ferrannini E, Monzani F: Type I interferons modulate the expression of thyroid peroxidase, sodium/iodide symporter, and thyroglobulin genes in primary human thyrocyte cultures. J Clin Endocrinol Metab 2005, 90:1156-1162
22. Gerard AC, Boucquey M, van den Hove MF, Colin IM: Expression of TPO and ThOXs in human thyrocytes is downregulated by IL-1alpha/IFN-gamma, an effect partially mediated by nitric oxide. Am J Physiol Endocrinol Metab 2006, 291:E242-E253
23. Sato K, Satoh T, Shizume K, Ozawa M, Han DC, Imamura H, Tsushima T, Demura H, Kanaji Y, Ito Y: Inhibition of 125I organification and thyroid hormone release by interleukin-1, tumor necrosis factor-alpha, and interferon-gamma in human thyrocytes in suspension culture. J Clin Endocrinol Metab 1990, 70:1735-1743
24. Poncin S, Lengele B, Colin IM, Gerard AC: Differential interactions between Th1/Th2, Th1/Th3, and Th2/Th3 cytokines in the regulation of TPO and DUOX expression, and of thyroglobulin secretion in thyrocytes in vitro. Endocrinology 2008, 149:1534-1542
25. Corbett JA, Wang JL, Hughes JH, Wolf BA, Sweetland MA, Lancaster JR Jr, McDaniel ML: Nitric oxide and cyclic GMP formation induced by interleukin 1 beta in islets of Langerhans: evidence for an effector role of nitric oxide in islet dysfunction. Biochem J 1992, 287(Pt 1):229-235
26. Suarez-Pinzon WL, Strynadka K, Schulz R, Rabinovitch A: Mechanisms of cytokine-induced destruction of rat insulinoma cells: the role of nitric oxide. Endocrinology 1994, 134:1006-1010
27. Kasai K, Hattori Y, Nakanishi N, Manaka K, Banba N, Motohashi S, Shimoda S: Regulation of inducible nitric oxide production by cytokines in human thyrocytes in culture. Endocrinology 1995, 136:4261-4270
28. Motohashi S, Kasai K, Banba N, Hattori Y, Shimoda S: Nitric oxide inhibits cell growth in cultured human thyrocytes. Life Sci 1996, 59:L227-L234
29. Reimers JI, Rasmussen AK, Karlsen AE, Bjerre U, Liang H, Morin O, Andersen HU, Mandrup-Poulsen T, Burger AG, Feldt-Rasmussen U, Nerup J: Interleukin-1 beta inhibits rat thyroid cell function in vivo and in vitro by an NO-independent mechanism and induces hypothyroidism and accelerated thyroiditis in diabetes-prone BB rats. J Endocrinol 1996, 151:147-157
30. van den Hove MF, Stoenoiu MS, Croizet K, Couvreur M, Courtoy PJ, Devuyst O, Colin IM: Nitric oxide is involved in interleukin-1alpha-induced cytotoxicity in polarised human thyrocytes. J Endocrinol 2002, 173:177-185 (Pubitemid 34428904)
31. Harper RW, Xu C, Eiserich JP, Chen Y, Kao CY, Thai P, Setiadi H, Wu R: Differential regulation of dual NADPH oxidases/peroxidases: Duox1 and Duox2, by Th1 and Th2 cytokines in respiratory tract epithelium. FEBS Lett 2005, 579:4911-4917
32. Darlington LG, Stone TW: Antioxidants and fatty acids in the amelioration of rheumatoid arthritis and related disorders. Br J Nutr 2001, 85:251-269
33. Davies CM, Guilak F, Weinberg JB, Fermor B: Reactive nitrogen and oxygen species in interleukin-1-mediated DNA damage associated with osteoarthritis. Osteoarthritis Cartilage 2008, 16:624-630 (Pubitemid 351524696)
34. Suarez-Pinzon WL, Strynadka K, Rabinovitch A: Destruction of rat pancreatic islet beta-cells by cytokines involves the production of cytotoxic aldehydes. Endocrinology 1996, 137:5290-5296 (Pubitemid 26423087)
35. Rabinovitch A, Suarez-Pinzon WL, Strynadka K, Lakey JR, Rajotte RV: Human pancreatic islet beta-cell destruction by cytokines involves oxygen free radicals and aldehyde production. J Clin Endocrinol Metab 1996, 81:3197-3202 (Pubitemid 26296188)
36. Fusco A, Berlingieri MT, Di Fiore PP, Portella G, Grieco M, Vecchio G: One- and two-step transformations of rat thyroid epithelial cells by retroviral oncogenes. Mol Cell Biol 1987, 7:3365-3370
37. Nilsson M, Husmark J, Nilsson B, Tisell LE, Ericson LE: Primary culture of human thyrocytes in Transwell bicameral chamber: thyrotropin promotes polarization and epithelial barrier function. Eur J Endocrinol 1996, 135:469-480 (Pubitemid 26364949)
38. Weibel ER, Kistler GS, Scherle WF: Practical stereological methods for morphometric cytology. J Cell Biol 1966, 30:23-38
39. Tsai L, Szweda PA, Vinogradova O, Szweda LI: Structural characterization and immunochemical detection of a fluorophore derived from 4-hydroxy-2-nonenal and lysine. Proc Natl Acad Sci USA 1998, 95:7975-7980 (Pubitemid 28326051)
40. Song Y, Driessens N, Costa M, De Deken X, Detours V, Corvilain B, Maenhaut C, Miot F, Van SJ, Many MC, Dumont JE: Roles of hydrogen peroxide in thyroid physiology and disease. J Clin Endocrinol Metab 2007, 92:3764-3773
41. Denef JF, Many MC, van den Hove MF: Iodine-induced thyroid inhibition and cell necrosis: two consequences of the same free-radical mediated mechanism? Mol Cell Endocrinol 1996, 121:101-103
42. Taurog A, Dorris ML, Doerge DR: Mechanism of simultaneous iodination and coupling catalyzed by thyroid peroxidase. Arch Biochem Biophys 1996, 330:24-32
43. Rasmussen AK, Di MR, Diamant M, Feldt-Rasmussen U, Bendtzen K: Nitric oxide production is not involved in the effects of interleukin-1 beta on cAMP, thyroglobulin, and interleukin-6 in TSH-stimulated human thyroid cells. Autoimmunity 1994, 19:239-245
44. Sadowska AM, Manuel YK, De Backer WA: Antioxidant and anti-inflammatory efficacy of NAC in the treatment of COPD: discordant in vitro and in vivo dose-effects: a review. Pulm Pharmacol Ther 2007, 20:9-22
45. Stanislaus R, Gilg AG, Singh AK, Singh I: N-acetyl-L-cysteine ameliorates the inflammatory disease process in experimental autoimmune encephalomyelitis in Lewis rats. J Autoimmune Dis 2005, 2:4
46. Sharma R, Traore K, Trush MA, Rose NR, Burek CL: Intracellular adhesion molecule-1 up-regulation on thyrocytes by iodine of nonobese diabetic H2(h4) mice is reactive oxygen species-dependent. Clin Exp Immunol 2008, 152:13-20
47. Gillissen A, Nowak D: Characterization of N-acetylcysteine and ambroxol in anti-oxidant therapy. Respir Med 1998, 92:609-623
48. Aruoma OI, Halliwell B, Hoey BM, Butler J: The antioxidant action of N-acetylcysteine: its reaction with hydrogen peroxide, hydroxyl radical, superoxide, and hypochlorous acid. Free Radic Biol Med 1989, 6:593-597 (Pubitemid 19147809)
49. Jiang C, Ting AT, Seed B: PPAR-gamma agonists inhibit production of monocyte inflammatory cytokines. Nature 1998, 391:82-86 (Pubitemid 28079219)
50. Cuzzocrea S: Peroxisome proliferator-activated receptors gamma ligands and ischemia and reperfusion injury. Vascul Pharmacol 2004, 41:187-195 (Pubitemid 40094612)
51. Petrova TV, Akama KT, Van Eldik LJ: Cyclopentenone prostaglandins suppress activation of microglia: down-regulation of inducible nitricoxide synthase by 15-deoxy-Delta12,14-prostaglandin J2. Proc Natl Acad Sci USA 1999, 96:4668-4673
52. Kim EH, Surh YJ: 15-deoxy-Delta12,14-prostaglandin J2 as a potential endogenous regulator of redox-sensitive transcription factors. Biochem Pharmacol 2006, 72:1516-1528
53. Vaidya S, Somers EP, Wright SD, Detmers PA, Bansal VS: 15-Deoxy-Delta12, 1412, 14-prostaglandin J2 inhibits the beta2 integrin-dependent oxidative burst: involvement of a mechanism distinct from peroxisome proliferator-activated receptor gamma ligation. J Immunol 1999, 163:6187-6192
54. Hortelano S, Castrillo A, Alvarez AM, Bosca L: Contribution of cyclopentenone prostaglandins to the resolution of inflammation through the potentiation of apoptosis in activated macrophages. J Immunol 2000, 165:6525-6531
55. Rigutto S, Hoste C, Dumont JE, Corvilain B, Miot F, De Deken X: Duox1 is the main source of hydrogen peroxide in the rat thyroid cell line PCCl3. Exp Cell Res 2007, 313:3892-3901 (Pubitemid 47566377)